Cargando…
Targeting the CXCR4/CXCL12 axis with the peptide antagonist E5 to inhibit breast tumor progression
Emerging evidence has demonstrated that stromal cell-derived factor 1 (SDF-1) and its cognate receptor CXCR4 have critical roles in tumorigenesis, angiogenesis and metastasis. In this study, we demonstrated the significant inhibitory effects of a novel chemically synthetic peptide (E5) on the CXCR4/...
Autores principales: | Guo, Hua, Ge, Yangyang, Li, Xiaojin, Yang, Yanlian, Meng, Jie, Liu, Jian, Wang, Chen, Xu, Haiyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5661635/ https://www.ncbi.nlm.nih.gov/pubmed/29263923 http://dx.doi.org/10.1038/sigtrans.2017.33 |
Ejemplares similares
-
Improving chemotherapeutic efficiency in acute myeloid leukemia treatments by chemically synthesized peptide interfering with CXCR4/CXCL12 axis
por: Li, Xiaojin, et al.
Publicado: (2015) -
A designed peptide targeting CXCR4 displays anti-acute myelocytic leukemia activity in vitro and in vivo
por: Li, Xiaojin, et al.
Publicado: (2014) -
Anti-tumor activity of nanomicelles encapsulating CXCR4 peptide antagonist E5
por: Fang, Xiaocui, et al.
Publicado: (2017) -
Involvement of the CXCR7/CXCR4/CXCL12 Axis in the Malignant Progression of Human Neuroblastoma
por: Liberman, Julie, et al.
Publicado: (2012) -
Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists
por: Morimoto, Mamoru, et al.
Publicado: (2016)